QNTM Quantum BioPharma Ltd.
Healthcare$7.05-23.70%ClosedMarket Cap: $31.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
69.46
P/S
0.00
EV/EBITDA
-1.87
DCF Value
$0.09
FCF Yield
-13.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-621.8%
ROA
-206.8%
ROIC
819.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-2.9M | $-13.4M | $— | — |
| Q4 null | $0.00 | NaN% | $8.0M | $-3.0M | $— | — |
| FY null | $0.00 | NaN% | $-15.3M | $-26.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-4.7M | $-5.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-4.9M | $-9.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.4M | $-8.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-6.2M | $-5.4M | $— | — |
| FY null | $0.00 | NaN% | $-16.1M | $-14.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-4.2M | $-3.8M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.5M | $-3.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-2.3M | $-1.9M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-1.8M | $-1.3M | $-2.18 | — |